Guyatt H L, Snow R W, Evans D B
Wellcome Trust Centre for the Epidemiology of Infectious Disease, University of Oxford, UK.
Philos Trans R Soc Lond B Biol Sci. 1999 Apr 29;354(1384):827-35. doi: 10.1098/rstb.1999.0434.
An understanding of the epidemiology of a disease is central in evaluating the health impact and cost-effectiveness of control interventions. The epidemiology of life-threatening malaria is receiving renewed interest, with concerns that the implementation of preventive measures such as insecticide-treated bednets (ITNs) while protecting young children might in fact increase the risks of mortality and morbidity in older ages by delaying the acquisition of functional immunity. This paper aims to illustrate how a combined approach of epidemiology and economics can be used to (i) explore the long-term impact of changes in epidemiological profiles, and (ii) identify those variables that are critical in determining whether an intervention will be an efficient use of resources. The key parameters for determining effectiveness are the protective efficacy of ITNs (reduction in all-cause mortality), the malaria attributable mortality and the increased malaria-specific mortality risk due to delays in the acquisition of functional immunity. In particular, the analysis demonstrates that delayed immune acquisition is not a problem per se, but that the critical issue is whether it occurs immediately following the implementation of an ITN programme or whether it builds up slowly over time. In the 'worst case' scenario where ITNs immediately increase malaria-specific mortality due to reduced immunity, the intervention might actually cost lives. In other words, it might be better to not use ITNs. On the other hand, if reduced immunity takes two years to develop, ITNs would still fall into the category of excellent value for money compared to other health interventions, saving a year of life (YLL) at a cost of between US$25-30. These types of calculations are important in identifying the parameters which field researchers should be seeking to measure to address the important question of the net impact of delaying the acquisition of immunity through preventive control measures.
了解一种疾病的流行病学对于评估控制干预措施的健康影响和成本效益至关重要。危及生命的疟疾流行病学正重新受到关注,人们担心,诸如使用经杀虫剂处理的蚊帐(ITN)等预防措施在保护幼儿的同时,实际上可能会因延迟功能性免疫力的获得而增加老年人的死亡和发病风险。本文旨在说明如何将流行病学和经济学的综合方法用于:(i)探索流行病学特征变化的长期影响;(ii)确定那些对于判定一项干预措施是否能有效利用资源至关重要的变量。确定有效性的关键参数包括ITN的保护效力(全因死亡率的降低)、疟疾归因死亡率以及由于功能性免疫力获得延迟导致的疟疾特异性死亡风险增加。具体而言,分析表明,免疫获得延迟本身并非问题,关键问题在于它是在ITN项目实施后立即出现,还是随着时间缓慢累积。在“最坏情况”下,即ITN因免疫力降低立即增加疟疾特异性死亡率,这种干预措施实际上可能会导致生命损失。换句话说,可能不使用ITN更好。另一方面,如果免疫力降低需要两年时间才会出现,与其他卫生干预措施相比,ITN仍将属于性价比极高的类别,以25 - 30美元的成本挽救一年的生命(YLL)。这类计算对于确定实地研究人员为解决通过预防性控制措施延迟免疫力获得的净影响这一重要问题而应设法测量的参数很重要。